| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yoshihisa Hiromine, Shinsuke Noso, Hiromi Rakugi, Ken Sugimoto, Yasunori Takata, Tomohiro Katsuya, Masahiro Fukuda, Hiroshi Akasaka, Haruhiko Osawa, Yasuharu Tabara, Hiroshi Ikegam. Poor glycemic control rather than types of diabetes is a risk factor for sarcopenia in diabetes mellitus: The MUSCLES-DM study. Journal of diabetes investigation. 2022-07-07. PMID:35796583. |
we therefore studied the effect of the type of diabetes, glycemic control, and insulin therapy on the prevalence and characteristics of sarcopenia. |
2022-07-07 |
2023-08-14 |
Not clear |
| Yi-Ju Chen, Rathinasamy Baskaran, Ching Fang Chang, Zuhair M Mohammedsaleh, Wan-Teng Li. Decapeptide from Potato Hydrolysate Induces Myogenic Differentiation and Ameliorates High Glucose-Associated Modulations in Protein Synthesis and Mitochondrial Biogenesis in C2C12 Cells. Biomolecules. vol 12. issue 4. 2022-04-23. PMID:35454154. |
sarcopenia is characterized as an age-related loss of muscle mass that results in negative health consequences such as decreased strength, insulin resistance, slowed metabolism, increased body fat mass, and a substantially diminished quality of life. |
2022-04-23 |
2023-08-13 |
Not clear |
| Hayder A Giha, Osman A O Alamin, Mai S Sate. Diabetic sarcopenia: metabolic and molecular appraisal. Acta diabetologica. 2022-04-16. PMID:35429264. |
several diabetic myopathy etiological factors are discussed explicitly including; inflammation and immunological responses, with emphasis on tnfα and il-6 overproduction, oxidative stress, neuropathy and vasculopathy, aging sarcopenia, antidiabetic drugs, and insulin resistance as a denominator. |
2022-04-16 |
2023-08-13 |
Not clear |
| Hyungwoo Lee, Il Hyung Lee, JoonNyung Heo, Minyoul Baik, Hyungjong Park, Hye Sun Lee, Hyo Suk Nam, Young Dae Ki. Impact of Sarcopenia on Functional Outcomes Among Patients With Mild Acute Ischemic Stroke and Transient Ischemic Attack: A Retrospective Study. Frontiers in neurology. vol 13. 2022-04-04. PMID:35370897. |
sarcopenia, a age-related disease characterized by loss of muscle mass accompanied by loss of function, is associated with nutrition imbalance, physical inactivity, insulin resistance, inflammation, metabolic syndrome, and atherosclerosis which are risk factors for cardiovascular disease. |
2022-04-04 |
2023-08-13 |
Not clear |
| Yong He, Fing Ding, Mengting Yin, He Zhang, Lisha Hou, Tao Cui, Jinfeng Xu, Jirong Yue, Qin Zhen. High Serum AST/ALT Ratio and Low Serum INS*PA Product Are Risk Factors and Can Diagnose Sarcopenia in Middle-Aged and Older Adults. Frontiers in endocrinology. vol 13. 2022-04-04. PMID:35370985. |
the present study was based on the asian working group on sarcopenia 2019 (awgs 2019) criteria to assess whether aspartate aminotransferase/alanine aminotransferase (ast/alt) ratio and fasting insulin*prealbumin (ins*pa) product are diagnostic markers associated with sarcopenia in various ethnic groups in western china. |
2022-04-04 |
2023-08-13 |
Not clear |
| Novira Widajanti, SoebagijoAdi Soelistijo, Usman Hadi, Mochammad Thaha, Aditiawardana, Widodo, Hadiq Firdausi, YafanitaIzzati Nurina, MiraDelima Asikin, Hersih Srinowati, NoerHalimatus Syakdiya. Association between Sarcopenia and Insulin-Like Growth Factor-1, Myostatin, and Insulin Resistance in Elderly Patients Undergoing Hemodialysis. Journal of aging research. vol 2022. 2022-04-04. PMID:35371569. |
association between sarcopenia and insulin-like growth factor-1, myostatin, and insulin resistance in elderly patients undergoing hemodialysis. |
2022-04-04 |
2023-08-13 |
human |
| Novira Widajanti, SoebagijoAdi Soelistijo, Usman Hadi, Mochammad Thaha, Aditiawardana, Widodo, Hadiq Firdausi, YafanitaIzzati Nurina, MiraDelima Asikin, Hersih Srinowati, NoerHalimatus Syakdiya. Association between Sarcopenia and Insulin-Like Growth Factor-1, Myostatin, and Insulin Resistance in Elderly Patients Undergoing Hemodialysis. Journal of aging research. vol 2022. 2022-04-04. PMID:35371569. |
this study aims to investigate the correlation of insulin-like growth factor-1 (igf-1) levels as an anabolic factor, myostatin levels, and insulin resistance as catabolic factors with sarcopenia in the pathogenesis of sarcopenia in elderly patients undergoing hemodialysis. |
2022-04-04 |
2023-08-13 |
human |
| Cydne A Perry, Gary P Van Guilder, Tammy A Butteric. Decreased myostatin in response to a controlled DASH diet is associated with improved body composition and cardiometabolic biomarkers in older adults: results from a controlled-feeding diet intervention study. BMC nutrition. vol 8. issue 1. 2022-03-15. PMID:35287731. |
myostatin is a mediator of sarcopenia and is associated with insulin resistance. |
2022-03-15 |
2023-08-13 |
Not clear |
| Nibedita Priyadarsini, Pranati Nanda, Sujata Devi, Subarna Mohapatr. Sarcopenia: An Age-Related Multifactorial Disorder. Current aging science. 2022-03-07. PMID:35249518. |
factors involved in the development of age-related sarcopenia include anorexia, alteration in the hormone levels, decreased neural innervation, low blood flow to the muscles, cytokine dysregulation, altered mitochondrial activity, genomic instability, intracellular proteolysis, and insulin resistance. |
2022-03-07 |
2023-08-13 |
Not clear |
| Chun-Wei Li, Kang Yu, Ng Shyh-Chang, Zongmin Jiang, Taoyan Liu, Shilin Ma, Lanfang Luo, Lu Guang, Kun Liang, Wenwu Ma, Hefan Miao, Wenhua Cao, Ruirui Liu, Ling-Juan Jiang, Song-Lin Yu, Chao Li, Hui-Jun Liu, Long-Yu Xu, Rong-Ji Liu, Xin-Yuan Zhang, Gao-Shan Li. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. Journal of cachexia, sarcopenia and muscle. 2022-02-02. PMID:35106971. |
patients with so show an increased risk of systemic insulin resistance, systemic inflammation, associated chronic diseases, and the subsequent progression to full-blown sarcopenia and even cachexia. |
2022-02-02 |
2023-08-13 |
human |
| Takuya Omura, Atsushi Arak. Skeletal muscle as a treatment target for older adults with diabetes mellitus: The importance of a multimodal intervention based on functional category. Geriatrics & gerontology international. 2022-01-05. PMID:34986525. |
although no specific drug enhances muscle mass and function, antidiabetic drugs that increase insulin sensitivity or secretion could be candidates for improvement of sarcopenia. |
2022-01-05 |
2023-08-13 |
Not clear |
| Nana He, Yuelin Zhang, Lu Zhang, Shun Zhang, Honghua Y. Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview. Frontiers in cardiovascular medicine. vol 8. 2021-12-27. PMID:34957238. |
sarcopenia may induce cvds through common pathogenic pathways such as malnutrition, physical inactivity, insulin resistance, inflammation; these mechanisms interact. |
2021-12-27 |
2023-08-13 |
Not clear |
| Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Elisabetta Bugianes. The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review. Frontiers in endocrinology. vol 12. 2021-12-04. PMID:34858322. |
the impact of dysmetabolic sarcopenia among insulin sensitive tissues: a narrative review. |
2021-12-04 |
2023-08-13 |
Not clear |
| Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Elisabetta Bugianes. The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review. Frontiers in endocrinology. vol 12. 2021-12-04. PMID:34858322. |
impaired insulin activity in sm is responsible for the altered molecular pathways and clinical manifestations of sarcopenia, which is morphologically expressed by myosteatosis. |
2021-12-04 |
2023-08-13 |
Not clear |
| Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Elisabetta Bugianes. The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review. Frontiers in endocrinology. vol 12. 2021-12-04. PMID:34858322. |
the gut-muscle axis has gain relevance with the evidence that insulin resistance-derived gut dysbiosis is responsible for increased endotoxemia and reduction in short-chain free fatty acids, directly affecting and predisposing to sarcopenia. |
2021-12-04 |
2023-08-13 |
Not clear |
| Elena Massimino, Anna Izzo, Gabriele Riccardi, Giuseppe Della Pep. The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms. Cells. vol 10. issue 8. 2021-11-11. PMID:34440727. |
mounting evidence suggests that the prevalence of sarcopenia is higher in patients with type 2 diabetes mellitus (t2dm), and different mechanisms may be responsible for this association such as impaired insulin sensitivity, chronic hyperglycemia, advanced glycosylation end products, subclinical inflammation, microvascular and macrovascular complications. |
2021-11-11 |
2023-08-13 |
Not clear |
| Munehiro Kitada, Daisuke Koy. Autophagy in metabolic disease and ageing. Nature reviews. Endocrinology. vol 17. issue 11. 2021-11-10. PMID:34508250. |
for example, sarcopenia is an age-related loss of skeletal muscle mass and strength that is involved in the pathogenesis of both insulin resistance and t2dm, particularly in elderly people. |
2021-11-10 |
2023-08-13 |
Not clear |
| Olga Maria Nardone, Roberto de Sire, Valentina Petito, Anna Testa, Guido Villani, Franco Scaldaferri, Fabiana Castiglion. Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure. Frontiers in immunology. vol 12. 2021-11-01. PMID:34326845. |
several factors are involved in the pathogenesis of sarcopenia, such as aging, inflammation, mitochondrial dysfunction, and insulin resistance. |
2021-11-01 |
2023-08-13 |
Not clear |
| Ozkan Gungor, Sena Ulu, Nuri Baris Hasbal, Stefan D Anker, Kamyar Kalantar-Zade. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do? Journal of cachexia, sarcopenia and muscle. 2021-10-22. PMID:34676694. |
hormones that may influence the development of sarcopenia are testosterone, growth hormone, insulin, thyroid hormones, and vitamin d. although the relationship between free testosterone level that is low in uraemic patients and sarcopenia in ckd is not well-defined, functional improvement may be seen. |
2021-10-22 |
2023-08-13 |
Not clear |
| Susanne N Wijesinghe, Thomas Nicholson, Kostas Tsintzas, Simon W Jone. Involvements of long noncoding RNAs in obesity-associated inflammatory diseases. Obesity reviews : an official journal of the International Association for the Study of Obesity. vol 22. issue 4. 2021-10-15. PMID:33078547. |
we highlight the evidence for their differential expression in the obese state and in age-related conditions including insulin resistance, type 2 diabetes (t2d), sarcopenia, osteoarthritis and rheumatoid arthritis, where obesity plays a significant role. |
2021-10-15 |
2023-08-13 |
Not clear |